• 1. Fatty acid eutectic mixtures and derivatives from non-edible animal fat as phase change materials?
  Pau Gallart-Sirvent,Marc Martín,Gemma Villorbina,Mercè Balcells,Aran Solé,Luisa F. Cabeza,Ramon Canela-Garayoa RSC Adv., 2017,7, 24133-24139
• 2. Distinct impact of glycation towards the aggregation and toxicity of murine and human amyloid-β?
  Eunju Nam,Jiyeon Han,Sunhee Choi,Mi Hee Lim Chem. Commun., 2021,57, 7637-7640
• 3. Evolution of important glucosinolates in three common Brassica vegetables during their processing into vegetable powder and in vitro gastric digestion
  Nan Fu,Naphaporn Chiewchan,Xiao Dong Chen Food Funct., 2020,11, 211-220
• 4. Enabling shape memory and healable effects in a conjugated polymer by incorporating siloxane via dynamic imine bond?
  Yaling Zhang,Chunhui Dai,Shiwei Zhou,Bin Liu Chem. Commun., 2018,54, 10092-10095
• 5. Dissociative electron attachment to HGaF4 Lewis–Br?nsted superacid
  Marcin Czapla,Jack Simons Phys. Chem. Chem. Phys., 2018,20, 21739-21745

Professional Introduction to N-ISOBUTYL-4-NITROBENZENESULFONAMIDE (CAS No. 89840-80-2)

N-ISOBUTYL-4-NITROBENZENESULFONAMIDE, a compound with the chemical identifier CAS No. 89840-80-2, is a specialized chemical entity that has garnered significant attention in the field of pharmaceutical and biochemical research. This compound, characterized by its unique molecular structure, has been studied for its potential applications in various scientific domains, particularly in drug development and molecular biology.

The molecular structure of N-ISOBUTYL-4-NITROBENZENESULFONAMIDE consists of a nitrobenzene core substituted with an isobutyl group and a sulfonamide functional group. This configuration imparts distinct chemical properties that make it a valuable candidate for synthetic chemistry and pharmacological investigations. The nitro group introduces a region of high reactivity, while the sulfonamide moiety enhances solubility and bioavailability, making it an attractive scaffold for medicinal chemistry.

In recent years, there has been a surge in research focused on developing novel therapeutic agents with improved efficacy and reduced side effects. N-ISOBUTYL-4-NITROBENZENESULFONAMIDE has emerged as a promising compound in this context. Its unique structural features have been leveraged to design molecules that interact selectively with biological targets, thereby potentially offering new treatments for various diseases.

One of the most compelling aspects of N-ISOBUTYL-4-NITROBENZENESULFONAMIDE is its role in the synthesis of bioactive molecules. Researchers have utilized this compound as a key intermediate in the preparation of more complex pharmaceuticals. Its ability to undergo various chemical transformations makes it a versatile building block for drug discovery efforts. For instance, the nitro group can be reduced to an amine, allowing for further functionalization and the creation of new pharmacophores.

The sulfonamide group in N-ISOBUTYL-4-NITROBENZENESULFONAMIDE also contributes to its biological activity. Sulfonamides are well-known for their antimicrobial properties and have been widely used in antibiotics and anti-inflammatory drugs. The presence of this moiety suggests that derivatives of this compound may exhibit similar therapeutic effects, making it a valuable candidate for further exploration.

Recent studies have begun to uncover the potential of N-ISOBUTYL-4-NITROBENZENESULFONAMIDE in modulating biological pathways relevant to human health. Researchers have investigated its interactions with enzymes and receptors, providing insights into its mechanism of action. These studies have highlighted its potential as an inhibitor or activator of various cellular processes, which could lead to novel therapeutic applications.

The synthesis of N-ISOBUTYL-4-NITROBENZENESULFONAMIDE itself is an intricate process that requires precise control over reaction conditions. Advanced synthetic techniques have been employed to optimize yield and purity, ensuring that researchers have access to high-quality material for their studies. The development of efficient synthetic routes has been crucial in enabling further exploration of this compound's potential.

In conclusion, N-ISOBUTYL-4-NITROBENZENESULFONAMIDE (CAS No. 89840-80-2) represents a significant advancement in the field of pharmaceutical chemistry. Its unique structural features and versatile reactivity make it a valuable tool for drug discovery and molecular biology research. As scientific understanding continues to evolve, it is likely that this compound will play an increasingly important role in the development of new treatments for human diseases.

• 89840-73-3(Benzenesulfonamide, N-(2-methylpropyl)-3-nitro-)
• 549476-61-1(N-Cyclopropyl 4-Nitrophenylsulfonamide)
• 66473-14-1(N-Butyl-4-nitrobenzenesulfonamide)
• 89840-81-3(Benzenesulfonamide, N-(1-methylpropyl)-4-nitro-)
• 23530-47-4(4-Nitro-N-Propyl-Benzenesulfonamide)
• 28860-09-5(N-Ethyl-3-nitrobenzenesulfonamide)
• 28860-08-4(N-Ethyl-4-nitrobenzenesulfonamide)
• 401589-92-2(N-Cyclopropyl-3-Nitrobenzenesulfonamide)
• 52374-18-2(Benzenesulfonamide,N-hexyl-4-nitro-)
• 52374-21-7(Benzenesulfonamide, 4-nitro-N-octyl-)